Stock Price
109.14
Daily Change
-6.48 -5.60%
Monthly
-23.57%
Yearly
60.22%
Q2 Forecast
106.95

Insmed reported $73.38M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Cytokinetics USD 24.71M 80.91M Mar/2026
DBV Technologies USD 39.82M 972K Sep/2025
Gilead Sciences USD 645M 70M Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Insmed USD 73.38M 6.53M Mar/2026
Novartis USD 4.46B 99M Dec/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026